Global Active Implantable Medical Devices Market Size, Share, Development, Growth and Demand Forecast to 2023 - Industry Insight by Product (Implantable Cardioverter Defibrillators, Neurostimulators, Implantable Cardiac Pacemakers, Implantable Hearing Devices, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop Recorders)

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market segmentation by product

1.3.2 Market segmentation by geography

1.3.3 Analysis period

1.3.4 Market data reporting unit

1.3.4.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of primary research respondents

2.2.1.1 By region

2.2.1.2 By industry participants

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Market Breakdown and Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

3.1 Key Findings

3.2 Research Summary

Chapter 4. Introduction

4.1 Market Segmentation

4.1.1 Overview by Product

4.1.1.1 Implantable cardioverter defibrillator (ICD)

4.1.1.1.1 Transvenous ICD (T-ICD)

4.1.1.1.1.1 Biventricular ICD

4.1.1.1.1.2 Dual chamber ICD

4.1.1.1.1.3 Single chamber ICD

4.1.1.1.2 Subcutaneous ICD (S-ICD)

4.1.1.2 Neurostimulator

4.1.1.2.1 Spinal cord stimulator (SCS)

4.1.1.2.2 Deep brain stimulator (DBS)

4.1.1.2.3 Sacral nerve stimulator (SNS)

4.1.1.2.4 Vagus nerve stimulator (VNS)

4.1.1.2.5 Gastric electrical stimulator (GES)

4.1.1.3 Implantable cardiac pacemaker (ICP)

4.1.1.4 Implantable hearing device (IHD)

4.1.1.4.1 Active hearing implant

4.1.1.4.2 Passive hearing implant

4.1.1.5 Ventricular assist device (VAD)

4.1.1.6 Implantable heart monitor (IHM)/ insertable loop recorder (ILR)

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Adoption of miniaturized implants

4.2.1.2 Market consolidation

4.2.1.3 Development of advanced hearing implants

4.2.2 Drivers

4.2.2.1 Increasing prevalence of cardiovascular diseases and neurological disorders

4.2.2.2 Technologically advanced active implantable devices

4.2.2.3 Increasing R&D investments

4.2.2.4 Growing aging population

4.2.2.5 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 High cost of active implantable devices and lack of skilled professionals

4.2.3.2 Risk associated with active implantable medical devices

4.2.3.3 Unfavorable healthcare reforms in U.S.

4.2.3.4 Stringent regulatory requirements

4.2.3.5 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Growing active implantable medical device market in emerging countries

4.2.4.2 Evolution of S-ICD

4.3 Porter's Five Forces Analysis

4.3.1 Bargaining power of buyers

4.3.2 Bargaining power of suppliers

4.3.3 Threat of new entrants

4.3.4 Intensity of rivalry

4.3.5 Threat of substitutes

Chapter 5. Market Size and Forecast by Product

5.1 Global ICD Market

5.1.1 Global ICD market, by type

5.1.1.1 Global T-ICD market, by type

5.1.2 Global ICD market, by region

5.2 Global Neurostimulator Market

5.2.1 Global neurostimulator market, by type

5.2.2 Global neurostimulator market, by region

5.3 Global ICP Market

5.3.1 Global ICP market, by region

5.4 Global IHD Market

5.4.1 Global IHD market, by type

5.4.2 Global IHD market, by region

5.5 Global VAD Market

5.5.1 Global VAD market, by region

5.6 Global IHM/ILR Market

5.6.1 Global IHM/ILR market, by region

Chapter 6. Market Size and Forecast by Geography

6.1 North America Active Implantable Medical Device Market

6.1.1 North America Active Implantable Medical Device Market, by Product

6.1.1.1 North America ICD market, by type

6.1.1.1.1 North America T-ICD market, by type

6.1.1.2 North America neurostimulator market, by type

6.1.1.3 North America IHD market, by type

6.1.2 North America Active Implantable Medical Device Market, by Country

6.2 Europe Active Implantable Medical Device Market

6.2.1 Europe Active Implantable Medical Device Market, by Product

6.2.1.1 Europe ICD market, by type

6.2.1.1.1 Europe T-ICD market, by type

6.2.1.2 Europe neurostimulator market, by type

6.2.1.3 Europe IHD market, by type

6.2.2 Europe Active Implantable Medical Device Market, by Country

6.3 Asia-Pacific Active Implantable Medical Device Market

6.3.1 Asia-Pacific Active Implantable Medical Device Market, by Product

6.3.1.1 Asia-Pacific ICD market, by type

6.3.1.1.1 Asia-Pacific T-ICD market, by type

6.3.1.2 Asia-Pacific neurostimulator market, by type

6.3.1.3 Asia-Pacific IHD market, by type

6.3.2 Asia-Pacific Active Implantable Medical Device Market, by Country

6.4 Latin America Active Implantable Medical Device Market

6.4.1 LATAM Active Implantable Medical Device Market, by Product

6.4.1.1 LATAM ICD market, by type

6.4.1.1.1 LATAM T-ICD market, by type

6.4.1.2 LATAM neurostimulator market, by type

6.4.1.3 LATAM IHD market, by type

6.4.2 LATAM Active Implantable Medical Device Market, by Country

6.5 Middle East & Africa (MEA) Active Implantable Medical Device Market

6.5.1 MEA active implantable medical device market, by product

6.5.1.1 MEA ICD market, by type

6.5.1.1.1 MEA T-ICD market, by type

6.5.1.2 MEA neurostimulator market, by type

6.5.1.3 MEA IHD market, by type

Chapter 7. Competitive Landscape

7.1 Product Benchmarking of Key Players in the Global Active Implantable Medical Device Market

7.2 Global Strategic Developments

7.2.1 Product Launch/Approval

7.2.2 Merger and Acquisition

7.2.3 Business Expansion

Chapter 8. Company Profiles

8.1 Abbott Laboratories

8.1.1 Business Overview

8.1.2 Product and Service Offerings

8.2 Medtronic plc

8.2.1 Business Overview

8.2.2 Product and Service Offerings

8.3 Boston Scientific Corporation

8.3.1 Business Overview

8.3.2 Product and Service Offerings

8.4 Biotronik SE & Co. KG

8.4.1 Business Overview

8.4.2 Product and Service Offerings

8.5 LivaNova PLC

8.5.1 Business Overview

8.5.2 Product and Service Offerings

8.6 William Demant Holding A/S

8.6.1 Business Overview

8.6.2 Product and Service Offerings

8.7 Sonova Holding AG

8.7.1 Business Overview

8.7.2 Product and Service Offerings

8.8 MED-EL

8.8.1 Business Overview

8.8.2 Product and Service Offerings

8.9 Cochlear Ltd.

8.9.1 Business Overview

8.9.2 Product and Service Offerings

8.1 Nurotron Biotechnology Co., Ltd.

8.10.1 Business Overview

8.10.2 Product and Service Offerings

Chapter 9. Appendix

9.1 Abbreviations

 

LIST OF TABLES

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET SNAPSHOT

TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 5 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT, $M (2013 - 2016)

TABLE 6 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT, $M (2017 - 2023)

TABLE 7 GLOBAL ICD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 8 GLOBAL ICD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 9 GLOBAL T-ICD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 10 GLOBAL T-ICD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 11 GLOBAL ICD MARKET, BY REGION, $M (2013 - 2016)

TABLE 12 GLOBAL ICD MARKET, BY REGION, $M (2017 - 2023)

TABLE 13 GLOBAL NEUROSTIMULATOR MARKET, BY TYPE, $M (2013 - 2016)

TABLE 14 GLOBAL NEUROSTIMULATOR MARKET, BY TYPE, $M (2017 - 2023)

TABLE 15 GLOBAL NEUROSTIMULATOR MARKET, BY REGION, $M (2013 - 2016)

TABLE 16 GLOBAL NEUROSTIMULATOR MARKET, BY REGION, $M (2017 - 2023)

TABLE 17 GLOBAL ICP MARKET, BY REGION, $M (2013 - 2016)

TABLE 18 GLOBAL ICP MARKET, BY REGION, $M (2017 - 2023)

TABLE 19 GLOBAL IHD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 20 GLOBAL IHD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 21 GLOBAL IHD MARKET, BY REGION, $M (2013 - 2016)

TABLE 22 GLOBAL IHD MARKET, BY REGION, $M (2017 - 2023)

TABLE 23 GLOBAL VAD MARKET, BY REGION, $M (2013 - 2016)

TABLE 24 GLOBAL VAD MARKET, BY REGION, $M (2017 - 2023)

TABLE 25 GLOBAL IHM/ILR MARKET, BY REGION, $M (2013 - 2016)

TABLE 26 GLOBAL IHM/ILR MARKET, BY REGION, $M (2017 - 2023)

TABLE 27 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT, $M (2013 - 2016)

TABLE 28 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT, $M (2017 - 2023)

TABLE 29 NORTH AMERICA ICD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 30 NORTH AMERICA ICD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 31 NORTH AMERICA T-ICD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 32 NORTH AMERICA T-ICD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 33 NORTH AMERICA NEUROSTIMULATOR MARKET, BY TYPE, $M (2013 - 2016)

TABLE 34 NORTH AMERICA NEUROSTIMULATOR MARKET, BY TYPE, $M (2017 - 2023)

TABLE 35 NORTH AMERICA IHD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 36 NORTH AMERICA IHD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 37 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY COUNTRY, $M (2013 - 2016)

TABLE 38 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY COUNTRY, $M (2017 - 2023)

TABLE 39 EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT, $M (2013 - 2016)

TABLE 40 EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT, $M (2017 - 2023)

TABLE 41 EUROPE ICD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 42 EUROPE ICD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 43 EUROPE T-ICD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 44 EUROPE T-ICD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 45 EUROPE NEUROSTIMULATOR MARKET, BY TYPE, $M (2013 - 2016)

TABLE 46 EUROPE NEUROSTIMULATOR MARKET, BY TYPE, $M (2017 - 2023)

TABLE 47 EUROPE IHD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 48 EUROPE IHD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 49 EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY COUNTRY, $M (2013 - 2016)

TABLE 50 EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY COUNTRY, $M (2017 - 2023)

TABLE 51 ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT, $M (2013 - 2016)

TABLE 52 ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT, $M (2017 - 2023)

TABLE 53 ASIA-PACIFIC ICD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 54 ASIA-PACIFIC ICD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 55 ASIA-PACIFIC T-ICD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 56 ASIA-PACIFIC T-ICD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 57 ASIA-PACIFIC NEUROSTIMULATOR MARKET, BY TYPE, $M (2013 - 2016)

TABLE 58 ASIA-PACIFIC NEUROSTIMULATOR MARKET, BY TYPE, $M (2017 - 2023)

TABLE 59 ASIA-PACIFIC IHD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 60 ASIA-PACIFIC IHD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 61 ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY COUNTRY, $M (2013 - 2016)

TABLE 62 ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY COUNTRY, $M (2017 - 2023)

TABLE 63 LATAM ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT, $M (2013 - 2016)

TABLE 64 LATAM ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT, $M (2017 - 2023)

TABLE 65 LATAM ICD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 66 LATAM ICD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 67 LATAM T-ICD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 68 LATAM T-ICD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 69 LATAM NEUROSTIMULATOR MARKET, BY TYPE, $M (2013 - 2016)

TABLE 70 LATAM NEUROSTIMULATOR MARKET, BY TYPE, $M (2017 - 2023)

TABLE 71 LATAM IHD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 72 LATAM IHD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 73 LATAM ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY COUNTRY, $M (2013 - 2016)

TABLE 74 LATAM ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY COUNTRY, $M (2017 - 2023)

TABLE 75 MEA ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT, $M (2013 - 2016)

TABLE 76 MEA ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT, $M (2017 - 2023)

TABLE 77 MEA ICD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 78 MEA ICD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 79 MEA T-ICD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 80 MEA T-ICD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 81 MEA NEUROSTIMULATOR MARKET, BY TYPE, $M (2013 - 2016)

TABLE 82 MEA NEUROSTIMULATOR MARKET, BY TYPE, $M (2017 - 2023)

TABLE 83 MEA IHD MARKET, BY TYPE, $M (2013 - 2016)

TABLE 84 MEA IHD MARKET, BY TYPE, $M (2017 - 2023)

TABLE 85 ABBOTT LABORATORIES - AT A GLANCE

TABLE 86 MEDTRONIC PLC - AT A GLANCE

TABLE 87 BOSTON SCIENTIFIC CORPORATION- AT A GLANCE

TABLE 88 BIOTRONIK SE & CO. KG - AT A GLANCE

TABLE 89 LIVANOVA PLC - AT A GLANCE

TABLE 90 WILLIAM DEMANT HOLDING A/S - AT A GLANCE

TABLE 91 SONOVA HOLDING AG- AT A GLANCE

TABLE 92 MED-EL - AT A GLANCE

TABLE 93 COCHLEAR LTD - AT A GLANCE

TABLE 94 NUROTRON BIOTECHNOLOGYCO., LTD. - AT A GLANCE

 

LIST OF FIGURES

FIG 1 RESEARCH SCOPE FOR THE GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET

FIG 2 RESEARCH METHODOLOGY FOR THE GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH FOR THE GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET

FIG 8 AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION

FIG 9 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET

FIG 10 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, SNAPSHOT (2016)

FIG 11 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT, $M (2013 - 2023)

FIG 12 GLOBAL ICD MARKET, BY TYPE, $M (2013 - 2023)

FIG 13 GLOBAL T-ICD MARKET, BY TYPE, $M (2013 - 2023)

FIG 14 GLOBAL ICD MARKET, BY REGION, $M (2013 - 2023)

FIG 15 GLOBAL NEUROSTIMULATOR MARKET BY TYPE, $M (2013 - 2023)

FIG 16 GLOBAL NEUROSTIMULATOR MARKET, BY REGION, $M (2013 - 2023)

FIG 17 GLOBAL ICP MARKET, BY REGION, $M (2013 - 2023)

FIG 18 GLOBAL IHD MARKET, BY TYPE, $M (2013 - 2023)

FIG 19 GLOBAL IHD MARKET, BY REGION, $M (2013 - 2023)

FIG 20 GLOBAL VAD MARKET, BY REGION, $M (2013 - 2023)

FIG 21 GLOBAL IHM/ILR MARKET, BY REGION, $M (2013 - 2023)

FIG 22 WORLDWIDE MAJOR MARKETS FOR ACTIVE IMPLANTABLE MEDICAL DEVICES

FIG 23 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET SNAPSHOT

FIG 24 EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET SNAPSHOT

FIG 25 ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET SNAPSHOT

FIG 26 LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET SNAPSHOT

FIG 27 MEA ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET SNAPSHOT

FIG 28 PRODUCT BENCHMARKING OF KEY PLAYERS IN THE GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE